A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases

Publication date

2024-04-30

Authors

Schultze, Anna
Martin, Ivonne
Messina, Davide
Bots, SHORCID 0000-0002-4483-5582ISNI 0000000506342455
Belitser, S.ISNI 000000041942150X
José Carreras-Martínez, Juan
Correcher-Martinez, Elisa
Urchueguía-Fornes, Arantxa
Martín-Pérez, Mar
García-Poza, Patricia

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Introduction: The aim of this study was to assess the possible extent of bias due to violation of a core assumption (event-dependent exposures) when using self-controlled designs to analyse the association between COVID-19 vaccines and myocarditis. Methods: We used data from five European databases (Spain: BIFAP, FISABIO VID, and SIDIAP; Italy: ARS-Tuscany; England: CPRD Aurum) converted to the ConcePTION Common Data Model. Individuals who experienced both myocarditis and were vaccinated against COVID-19 between 1 September 2020 and the end of data availability in each country were included. We compared a self-controlled risk interval study (SCRI) using a pre-vaccination control window, an SCRI using a post-vaccination control window, a standard SCCS and an extension of the SCCS designed to handle violations of the assumption of event-dependent exposures. Results: We included 1,757 cases of myocarditis. For analyses of the first dose of the Pfizer vaccine, to which all databases contributed information, we found results consistent with a null effect in both of the SCRI and extended SCCS, but some indication of a harmful effect in a standard SCCS. For the second dose, we found evidence of a harmful association for all study designs, with relatively similar effect sizes (SCRI pre = 1.99, 1.40 – 2.82; SCRI post 2.13, 95 %CI – 1.43, 3.18; standard SCCS 1.79, 95 %CI 1.31 – 2.44, extended SCCS 1.52, 95 %CI = 1.08 – 2.15). Adjustment for calendar time did not change these conclusions. Findings using all designs were also consistent with a harmful effect following a second dose of the Moderna vaccine. Conclusions: In the context of the known association between COVID-19 vaccines and myocarditis, we have demonstrated that two forms of SCRI and two forms of SCCS led to largely comparable results, possibly because of limited violation of the assumption of event-dependent exposures.

Keywords

(MeSH): Vaccines, Electronic Health Records, Meta-analysis, Myocarditis, Pharmacoepidemiology, Self-controlled Case Series, Self-controlled Risk Interval, Molecular Medicine, General Immunology and Microbiology, General Veterinary, Public Health, Environmental and Occupational Health, Infectious Diseases, SDG 3 - Good Health and Well-being

Citation

Schultze, A, Martin, I, Messina, D, Bots, S, Belitser, S, José Carreras-Martínez, J, Correcher-Martinez, E, Urchueguía-Fornes, A, Martín-Pérez, M, García-Poza, P, Villalobos, F, Pallejà-Millán, M, Alberto Bissacco, C, Segundo, E, Souverein, P, Riefolo, F, Durán, C E, Gini, R, Sturkenboom, M, Klungel, O & Douglas, I 2024, 'A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases', Vaccine, vol. 42, no. 12, pp. 3039-3048. https://doi.org/10.1016/j.vaccine.2024.03.043